Drug profile · INN
misoprostol
CYTOTEC
misoprostol (CYTOTEC) is a prostanoid ep3 receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — misoprostol
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 6
- Data quality
- 0.84
Quick answer
misoprostol (CYTOTEC) is a prostanoid ep3 receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Prostanoid EP3 receptor agonist
Primary target: Prostaglandin E2 receptor EP3 subtype
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is misoprostol?
misoprostol (CYTOTEC) is a prostanoid ep3 receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for misoprostol?
CYTOTEC is a marketed brand name for misoprostol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of misoprostol?
misoprostol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.